Auxilium has a proven track record in identifying and consummating partnerships that create significant shareholder value for both parties. We recognize that each partner has unique needs, challenges, and internal considerations that must be addressed prior to entering into a deal. Auxilium is able to address these complexities and ensure expedient execution as a result of its flexibility, creativity, and perseverence.

In addition to its corporate culture, commitment to partnering, and perspective on deal-making, Auxilium believes it is a great partner due to the following attributes:

• Clear corporate strategy that is focused on select therapeutic areas
• Proven R&D capabilities (which enabled the development and approval of Testim^® in 22 months)
• Significant experience navigating the complex regulatory approval process
• Global development and regulatory capabilities in place
• Highly experienced commercial team in the U.S. that is supported by robust sales analytics
• A specialty salesforce of approximately 150 professionals
• Access and relationships with world-renowned KOLs within our therapeutic areas
• Alliance management function dedicated to the success of a partnership